99% Savings - Buy Just @1 Rs X
Covarace D is a commercial drug that is prescribed in the form of Tablet. Other than this, Covarace D has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Covarace D. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Covarace D can also lead to other problems, which have been listed below. Usually, these side effects of Covarace D go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Covarace D's effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Covarace D related warnings talks about Covarace D's effects on the liver, heart and kidney.
Covarace D can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Covarace D in conditions like Asthma, Allergy, Kidney Disease. Other conditions have been mentioned below in the Covarace D contraindications section.
Additionally, Covarace D may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Covarace D, it is important to know that it is not safe while driving, and is not habit-forming.
Covarace D is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Covarace D safe for pregnant women?
Covarace D can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Covarace D safe during breastfeeding?
Covarace D may have very limited harmful effects for breastfeeding women.
What is the effect of Covarace D on the Kidneys?
Very few cases of side effects of Covarace D on kidney have been reported.
What is the effect of Covarace D on the Liver?
Covarace D has very mild side effects on the liver.
What is the effect of Covarace D on the Heart?
Very few cases of side effects of Covarace D on the heart have been reported.
Covarace D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Covarace D unless your doctor advises you to do so -
Is this Covarace D habit forming or addictive?
Covarace D does not cause addiction.
Interaction between Food and Covarace D
Taking Covarace D with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Covarace D
No research has been done on this till date. Therefore, it is not known what the effect of taking Covarace D with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cozaar® (losartan potassium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 506
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503